Literature DB >> 15057873

LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane.

Takahide Ota1, Masayo Maeda, Shiho Suto, Masaaki Tatsuka.   

Abstract

Rho family GTPases play an important role in a number of processes related to metastasis, and RhoGDP dissociation, inhibitors (RhoGDIs) regulate Rho family proteins. We cloned genomic DNA from colon carcinoma SW480 cells capable of transforming nonmetastatic ras-transformed 1-1ras1000 cells into metastatic cells. This DNA contained a truncated human ras homolog gene family GDP dissociation inhibitor beta (ARHGDIB) gene, resulting in a C-terminal truncated form of LyGDI (Delta C-LyGDI, 166-201 deletion), a member of the RhoGDIs. The stable expression of Delta C-LyGDI induced pulmonary metastasis in 1-1ras1000 cells, whereas expression of full-length LyGDI did not induce metastasis. Delta C-LyGDI was preferentially localized in the membrane, detected in a NP-40-insoluble fraction, and co-purified with radixin, moesin, Rac1, Cdc42, and RhoA. In Delta C-LyGDI transfectant, an activation state of Rac1 was elevated and Delta C-LyGDI was associated with Rac1-GTP. In keeping with the observed localization of Rac1 to the cell membrane and the elevated level of Rac1-GTP, Delta C-LyGDI transfectants were found to be more invasive than mock transfectant. These results suggest that LyGDI functions in the cell membrane to afford spatial regulation of Rho family GTPase signaling through ezrin radixin moesin (ERM) proteins during metastasis. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15057873     DOI: 10.1002/mc.20006

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  13 in total

1.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

2.  Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.

Authors:  Yaqin Zhang; Leslie A Rivera Rosado; Sun Young Moon; Baolin Zhang
Journal:  J Biol Chem       Date:  2009-03-06       Impact factor: 5.157

Review 3.  RhoGDI: multiple functions in the regulation of Rho family GTPase activities.

Authors:  Athanassios Dovas; John R Couchman
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

4.  Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data.

Authors:  Tsuyoshi Yoshida; Takumi Kobayashi; Masaya Itoda; Taika Muto; Ken Miyaguchi; Kaoru Mogushi; Satoshi Shoji; Kazuro Shimokawa; Satoru Iida; Hiroyuki Uetake; Toshiaki Ishikawa; Kenichi Sugihara; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  Cancer Inform       Date:  2010-07-29

5.  Centrosomal localization of RhoGDIβ and its relevance to mitotic processes in cancer cells.

Authors:  Yong-Sheng Jiang; Masayo Maeda; Mayumi Okamoto; Mikiko Fujii; Ryuichiro Fukutomi; Masato Hori; Masaaki Tatsuka; Takahide Ota
Journal:  Int J Oncol       Date:  2012-12-07       Impact factor: 5.650

6.  Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways.

Authors:  Marcus Lehnhardt; Ludger Klein-Hitpass; Cornelius Kuhnen; Heinz Herbert Homann; Adrien Daigeler; Hans Ulrich Steinau; Sonja Roehrs; Laura Schnoor; Lars Steinstraesser; Oliver Mueller
Journal:  BMC Cancer       Date:  2005-07-07       Impact factor: 4.430

7.  Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Authors:  Arye Elfenbein; John M Rhodes; Julia Meller; Martin A Schwartz; Michiyuki Matsuda; Michael Simons
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

8.  Placenta-specific novel splice variants of Rho GDP dissociation inhibitor β are highly expressed in cancerous cells.

Authors:  Keiichi Hatakeyama; Yorikane Fukuda; Keiichi Ohshima; Masanori Terashima; Ken Yamaguchi; Tohru Mochizuki
Journal:  BMC Res Notes       Date:  2012-12-03

9.  TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.

Authors:  Adrien Daigeler; Christina Brenzel; Daniel Bulut; Anne Geisler; Christoph Hilgert; Marcus Lehnhardt; Hans U Steinau; Annegret Flier; Lars Steinstraesser; Ludger Klein-Hitpass; Ulrich Mittelkötter; Waldemar Uhl; Ansgar M Chromik
Journal:  J Exp Clin Cancer Res       Date:  2008-12-12

10.  RhoGDIbeta-induced hypertrophic growth in H9c2 cells is negatively regulated by ZAK.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-01-22       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.